Characterization of KIAA1427 protein as an atypical synaptotagmin (Syt XIII)

被引:44
作者
Fukuda, M
Mikoshiba, K
机构
[1] RIKEN, Brain Sci Inst, Dev Neurobiol Lab, Wako, Saitama 3510198, Japan
[2] Univ Tokyo, Inst Med Sci, Dept Basic Med Sci, Div Mol Neurobiol,Minato Ku, Tokyo 1088639, Japan
关键词
C2; domain; oligomerization; phospholipid binding; vesicle docking; vesicle transport;
D O I
10.1042/0264-6021:3540249
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Synaptotagmin (Syt) belongs to a family of type-I membrane proteins and is a protein that consists of a short extracellular N-terminus, a single transmembrane domain, two C2 domains and a short C-terminus. Here, we cloned and characterized a mouse orthologue of human KIAA1427 protein as an atypical Syt (named Syt XIII). Subcellular fractionation and antibody-uptake experiments indicate that Syt XIII is indeed a type-I membrane protein, but, unlike other Syt isoforms, lacks an N-terminal extracellular domain. Syt XIII C2 domains show relatively little similarity to Syt I (less than 35% identity at the amino acid level), and lack key amino acids responsible for Ca2+ binding. Because of these substitutions, the Syt XIII C2 domains did not show Ca2+-dependent phospholipid-binding activity, and Syt XIII is thus classified as a Ca2+-independent isoform. By contrast, the Syt XIII C-terminal domain is highly homologous with other Syt isoforms and can function as a common receptor for neurexin I alpha in vitro. Since Syt XIII is expressed in various tissues outside the brain, Syt XIII may be involved in constitutive vesicle transport.
引用
收藏
页码:249 / 257
页数:9
相关论文
共 57 条
  • [1] INHIBITION OF NEUROTRANSMITTER RELEASE BY C2-DOMAIN PEPTIDES IMPLICATES SYNAPTOTAGMIN IN EXOCYTOSIS
    BOMMERT, K
    CHARLTON, MP
    DEBELLO, WM
    CHIN, GJ
    BETZ, H
    AUGUSTINE, GJ
    [J]. NATURE, 1993, 363 (6425) : 163 - 165
  • [2] Synaptotagmin III isoform is compartmentalized in pancreatic β-cells and has a functional role in exocytosis
    Brown, H
    Meister, B
    Deeney, J
    Corkey, BE
    Yang, SN
    Larsson, O
    Rhodes, CJ
    Seino, S
    Berggren, PO
    Fried, G
    [J]. DIABETES, 2000, 49 (03) : 383 - 391
  • [3] Rabphilin-3A: A multifunctional regulator of synaptic vesicle traffic
    Burns, ME
    Sasaki, T
    Takai, Y
    Augustine, GJ
    [J]. JOURNAL OF GENERAL PHYSIOLOGY, 1998, 111 (02) : 243 - 255
  • [4] A novel function for the second C2 domain of synaptotagmin - Ca2+-triggered dimerization
    Chapman, ER
    An, S
    Edwardson, JM
    Jahn, R
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (10) : 5844 - 5849
  • [5] Delineation of the oligomerization, AP-2 binding, and synprint binding region of the C2B domain of synaptotagmin
    Chapman, ER
    Desai, RC
    Davis, AF
    Tornehl, CK
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (49) : 32966 - 32972
  • [6] Fatty acylation of synaptotagmin in PC12 cells and synaptosomes
    Chapman, ER
    Blasi, J
    An, S
    Brose, N
    Johnston, PA
    Sudhof, TC
    Jahn, R
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1996, 225 (01) : 326 - 332
  • [7] Alternative splicing of synaptotagmins involving transmembrane exon skipping
    Craxton, M
    Goedert, M
    [J]. FEBS LETTERS, 1999, 460 (03) : 417 - 422
  • [8] Damer CK, 1996, J NEUROCHEM, V67, P1661
  • [9] Detrait E, 2000, J NEUROBIOL, V44, P382, DOI 10.1002/1097-4695(20000915)44:4<382::AID-NEU2>3.0.CO
  • [10] 2-Q